Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-023975
Filing Date
2022-05-04
Accepted
2022-05-04 16:34:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea159380-13gfonda_tiziana.htm SC 13G 27769
  Complete submission text file 0001213900-22-023975.txt   29150
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Subject) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91460 | Film No.: 22892073
SIC: 2834 Pharmaceutical Preparations

Mailing Address 45 AVENUE DE GRANDE BRETAGNE MONTE CARLO O9 98000
Business Address
Fonda Laura Natalia Monica (Filed by) CIK: 0001921627 (see all company filings)

Type: SC 13G